Report : Global Vascular Closure Devices Market 2016-2020 is a new market research publication announced by Reportstack.
Report Outline: The global vascular closure devices market is likely to grow at a steady pace during the forecast period. This is because many clinical studies regarding vascular closure devices raised concerns about their safety and efficacy profiles. In many clinical cases, manual compressions were used as vascular closure devices that failed to show their efficacy. Vascular closure devices are used for both diagnostic and therapeutic interventions.
Concerns regarding these devices have led vendors to invest extensively in their R&D. These devices help in the diagnosis and treatment of cardiac diseases. A rise in the incidence of these diseases will lead to the demand and sales of vascular closure devices. The sales will further increase with the rapid adoption of minimally invasive equipment for cardiac surgeries. Minimally invasive surgeries such as angiography cause less pain, minimize infections, and help reduce hospital stay.
For detailed report with TOC, please click here Global Vascular Closure Devices Market 2016-2020.
Market Growth: The global vascular closure devices market is expected to grow at a CAGR of 8.67% during the period 2016-2020.
• Abbott Laboratories
• Cardinal Health
• St. Jude Medical
• Vascular Solutions
Other prominent vendors
• Beijing Puyishengji Medical Technology
• Essential Medical
• InSeal Medical
• Medeon Biodesign
• Morrris Innovative
• Transluminal Technologies
• Vascular Closure Systems
• Vivasure Medical
Abbott Laboratories, Cardinal Health, St. Jude Medical, Vascular Solutions, Arstasis, Beijing Puyishengji Medical Technology, Endocor, Essential Medical, InSeal Medical, Medeon Biodesign, Morrris Innovative, Transluminal Technologies, Vascular Closure Systems, Vasorum, Vivasure Medical.
Manager - Marketing
Reportstack Market Research